tamiflu linked to abnormal behaviour, page-5

Hi Portable,

The story is good for Relenza and I noticed that it was just published in the SMH.

I have topped up again on my BTA shares as I believe just like yourself that the perfect storm is brewing for this small BiotTech company.

We will imho outdo previous hights as Relenza is now left alone without another Antiviral being able to do the work it suppose to do.

The news is out and Tamiflop is egg on the face of all those governements who bought the product which at the time was already rated second to tamiflu by those specialist who studied it.

It shows again that with the right people behind the scene pushing a product you can just sell anything.

But now thats all gone and Relenza will become a great earner and Lani even better once Relenza is gone.

Good luck

jojo